Advertisement
Advertisement
NMTC
NeuroOne Medical Technologies Corporation Common Stock
0.79
USDSponsored
+0.05
+6.94%
Feb 06, 15:59 UTC -5
Closed
After-Market
0.78
-0.01
-0.89%
NMTC Earnings Reports
Positive Surprise Ratio
NMTC beat 13 of 16 last estimates.
81%
Next Report
Date of Next Report
Feb 17, 2026
Estimate for Q1 26 (Revenue/ EPS)
$2.73M
/-$0.04
Implied change from Q4 25 (Revenue/ EPS)
-0.34%
/--
Implied change from Q1 25 (Revenue/ EPS)
-16.47%
/-166.67%
NeuroOne Medical Technologies Corporation Common Stock earnings per share and revenue
On Dec 17, 2025, NMTC reported earnings of -0.04 USD per share (EPS) for Q4 25, beating the estimate of -0.04 USD, resulting in a 1.96% surprise. Revenue reached 2.74 million, compared to an expected 2.52 million, with a 8.79% difference. The market reacted with a +6.93% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 2.73 million USD, implying an increase of 0.00% EPS, and decrease of -0.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
FAQ
What were NeuroOne Medical Technologies Corporation Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, NeuroOne Medical Technologies Corporation Common Stock reported EPS of -$0.04, beating estimates by 1.96%, and revenue of $2.74M, 8.79% above expectations.
How did the market react to NeuroOne Medical Technologies Corporation Common Stock's Q4 2025 earnings?
The stock price moved up 6.93%, changed from $0.66 before the earnings release to $0.71 the day after.
When is NeuroOne Medical Technologies Corporation Common Stock expected to report next?
The next earning report is scheduled for Feb 17, 2026.
What are the forecasts for NeuroOne Medical Technologies Corporation Common Stock's next earnings report?
Based on 4
analysts, NeuroOne Medical Technologies Corporation Common Stock is expected to report EPS of -$0.04 and revenue of $2.73M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement